Gujarat Themis Biosyn Ltd allots ₹585 crore NCDs via private placement on 16-09-2026
Gujarat Themis Biosyn · Pharmaceuticals & Biotechnology
Key highlights
- Issued 58,500 secured, redeemable, unlisted, rated NCDs worth ₹585 crore in two series
- Series 1: 29,500 NCDs (₹295 crore), 60 months tenure, 10% p.a. interest compounded monthly
- Series 2: 29,000 NCDs (₹290 crore), 18 months tenure, 17.75% p.a. interest compounded monthly
Why it's rated notable: amount is ₹500 crore or more
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Gujarat Themis Biosyn
- Fundraise / allotmentNotableGujarat Themis Biosyn Limited announces dividend, fund raise, and AOA amendment
- Fundraise / allotmentNotableGujarat Themis Biosyn approves issuance of Non-Convertible Debentures up to ₹585 Cr
- Fundraise / allotmentNotableGujarat Themis Biosyn Limited closes QIP, approves 2,11,86,440 shares at ₹354 each
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentImagicaaworld EntertainmentImagicaaworld Entertainment reports Q2 & H1 FY27 financial results and strategic updates
- Fundraise / allotmentUnited Heat TransferUnited Heat Transfer Limited approves half-year financial results for Sept 2026
- Fundraise / allotmentJubilant PharmovaJubilant Pharmova reports Q2 and H1 FY27 financial results and operational updates
- Fundraise / allotmentNatural CapsulesNatural Capsules Limited approves Q2 2026 results and preferential allotment
- Fundraise / allotmentNatural CapsulesNatural Capsules Ltd announces Q2 FY27 results and approves preferential allotment
- Fundraise / allotmentDestiny Logistics & InfraDestiny Logistics & Infra Ltd announces key resignations, appointments, and warrant lapse
Potential multibaggers · Q2 FY27
Potential multibaggers in Pharmaceuticals & Biotechnology
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.